| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.002 | 1 |